North Valley Eye Medical Group

Mission Hills, California 91345

0 studies enrolling now · 21 studies all time

What they study most

Bacterial Infections, Blepharitis, Cataract Extraction, Chronic Ocular Pain, Dry Eye, Dry Eye Syndromes, Elevated Intraocular Pressure, Eye Infections, Glaucoma, Glaucoma and Ocular Hypertension, Keratoconjunctivitis Sicca, Ocular Hypertension

Studies at this site

• A Study to Assess the Safety and Efficacy of ECF843 vs Vehicle in Subjects With Dry Eye Disease — Completed
• Study of Efficacy and Safety of SAF312 Eye Drops in Subjects With Post-operative Corneal Induced Chronic Pain (CICP) — Completed
• Rocklatan® Evaluation — Completed
• Safety and Efficacy of Ophthalmic Phentolamine Mesylate in Glaucoma — Completed
• A Phase III Study Assessing the Efficacy and Safety of DE-117 Ophthalmic Solution Compared With Timolol Maleate Ophthalmic Solution 0.5% in Subjects With Glaucoma or Ocular Hypertension - Spectrum 3 Study — Completed
• DE-117 Spectrum 5 Study — Completed
• Multicenter Study Assessing the Efficacy and Safety of DE-126 Ophthalmic Solution 0.002% Compared With Timolol Maleate Ophthalmic Solution 0.5% in Subjects With Primary Open Angle Glaucoma or Ocular Hypertension — Completed
• Study to Assess the Efficacy, Safety and Tolerability of AKB-9778 Ophthalmic Solution as and Adjunct to Latanoprost in Patients With Ocular Hypertension or Open Angle Glaucoma — Completed
• Study to Evaluate the Safety and Efficacy of SDP-4 in Subjects With Dry Eye Disease (DED) — Completed
• Prospective, Double-masked, Randomized, Multi-center, Active-controlled, Parallel-group, 3-month Study Assessing the Safety & Ocular Hypotensive Efficacy of TC-002 Ophthalmic Solution Compared to Latanoprost Ophthalmic Solution 0.005% in Subjects With Elevated Intraocular Pressure — Status unconfirmed
• Safety and Efficacy of KPI-121 in Subjects With Dry Eye Disease — Completed
• Safety and Efficacy of KPI-121 in Subjects With Postsurgical Inflammation — Completed
• Safety and Efficacy of KPI-121 in Subjects With Inflammatory Meibomian Gland Disease — Completed
• Safety and Efficacy of KPI-121 in Subjects With Dry Eye Disease — Completed
• Safety and Efficacy of KPI-121 Compared to Placebo in Subjects With Dry Eye Disease — Completed
• A Phase IIb Safety and Efficacy Study of DE-126 Ophthalmic Solution in Primary Open-Angle Glaucoma or Ocular Hypertension- Angel Study — Completed
• A Study to Evaluate the Safety and Efficacy of EV06 Ophthalmic Solution in Improving Vision in Subjects With Presbyopia — Completed
• The Effects of Azithromycin Ophthalmic Solution, 1% Versus Placebo in Subjects With Blepharitis During a Four-Week Treatment Period (P08638) — Completed
• The Effects of Azithromycin Ophthalmic Solution, 1% Versus Placebo in Subjects With Blepharitis During a Two-Week Treatment Period — Completed
• Safety and Efficacy Pilot Study of AzaSite® (Azithromycin) in Subjects With Blepharitis — Completed
• Study of AzaSite Versus Vigamox Concentrations in the Conjunctiva and Aqueous Humor in Subjects Undergoing Routine Cataract Surgery — Completed